期刊文献+

51例APL患者PML/RARα mRNA转录本的检测及其意义 被引量:4

Detection of PML/RARα fusion gene transcript by real-time quantitative PCR
暂未订购
导出
摘要 目的建立实时定量聚合酶链反应(RQ-PCR)方法并检测初诊急性早幼粒细胞白血病(APL)患者甲幼粒细胞白血病/维甲酸受体(PML/RARα)融合基因含量,评价检测结果的临床意义。方法采用"欧洲抗癌计划"推荐的引物和探针建立RQ-PCR方法,检测51例初诊APL患者的PML/RARα融合基因含量,并分析其临床意义。结果 APL初诊患者的年龄与外周血白细胞(WBC)数呈负相关(r=-0.376,P=0.014),相关性主要见于长型和变异型患者(r=-0.51,P=0.005)。51例APL初诊患者中,长型患者33例,变异型患者3例,长型和变异型36例。APL初诊患者PML/RARα转录本绝对含量为3.75×102~6.20×105拷贝/50ng(中位7.24×103拷贝/50ng);相对含量为0.51%~676.87%(中位9.31%)。15例短型患者PML/RARα转录本绝对含量为2.26×103~2.33×106拷贝/50ng(中位1.17×105拷贝/50ng);相对含量为12.04%~802.68%(中位95.26%)。短型患者外周血WBC数明显高于长型患者(P=0.041),其融合基因含量也明显高于长型患者(P<0.01),而在性别、年龄、外周血Hb、PLT,骨髓原粒及异常早幼粒细胞比例、血液学缓解时间和分子生物学缓解时间等方面比较差异无统计学意义。33例初诊患者血液学缓解时间、分子生物学缓解时间与患者的年龄、WBC数及融合基因含量无相关性。结论 RQ-PCR方法敏感、可靠,可以对APL初诊患者进行诊断和分型。 Objective To establish the real time quantitative PCR(RQ-PCR) assay and analyze its results in detection and quantification PML/RARα fusion transcripts in newly diagnosed patients with acute promyelocytic leukemia(APL).Methods Three pairs of primer and TaqMan probe were designed according to ′Europe Against Cancer′(EAC) program for detecting the most frequent isoforms(Long-form,Short-form and Variant-form) of PML/RARα transcripts.To evaluate the utility of this assay,bone marrow samples from 51 newly diagnosed APL patients were detected and the results were analyzed.Results There was significant negative correlation between initial WBC count and the age of APL patients(r=-0.376,P=0.014),mainly seen in the patients with Long-form and the Variant-form(r=-0.51,P=0.005).In 51 newly diagnosed APL patients,there were 33 cases with Long-form PML/RARα transcripts,3 with Variant-form PML/RARα transcripts and 15 with Short-form PML/RARα transcripts.In 36 cases with Long-form or Variant-form transcripts,the median absolute and normalized amount of PML/RARα transcripts were 3.75×102-6.20×105 copies/50 ng(median 7.24×10^3 copies/50 ng) and 0.51%-676.87%(median 9.31%) respectively.In 15 cases with Short-form transcripts,the median absolute and normalized amount of PML/RARα transcripts were 2.26×103-2.33×106 copies/50 ng(median 1.17×10^5 copies/50 ng) and 12.04%-802.68%(median 95.26%) respectively.The WBC count was higher in the Short-form group than in the Long-form group(P=0.041).The normalized amount of Short-form PML/RARα transcripts was significantly higher than that of Long-form(P0.01).However,there was no statistical difference in the sex,age,Hb,PLT,proportion of the blast and promyelocyte in the bone marrow,the time of achieving hematologic complete remission and molecular complete remission between the Long-form patients and the Short-form patients.Among 33 cases with follow-up data,neither of the time of achieving hematologic complete remission nor molecular complete remission was correlated with the age,initial WBC and the expression level of the PML/RARα transcripts.Conclusion RQ-PCR for detecting the isoforms of PML/RARα fusion transcripts is a sensitive,reliable quantitative assay and can be used in the diagnosis of APL.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第1期1-3,7,共4页 Chongqing medicine
基金 江苏省医学重点人才基金资助项目(RC2007035) 江苏省自然基金资助项目(BK2009206) 镇江市社会发展基金资助项目(SH2008041)
关键词 聚合酶链反应 白血病 早幼粒细胞 急性 受体 维甲酸 polymerase chain reaction leukemia promyelocytic acute receptors retinoicacid
  • 相关文献

参考文献14

  • 1Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European Leukemia Net [J]. Blood, 2009,113(9) : 1875-1877.
  • 2Grimwade D, Biondi A, Mozziconacci M J, et al. Character- ization of acute promyelocytic leukemia cases lacking the classic t(15;17):results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Communi- ty-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies" [J]. Blood, 2000, 96 ( 8 ) : 1297-1299.
  • 3Kastner P, Lawrence HJ, Waltzinger C, et al. Positivean Negative Regulation of Granulopoiesis by Endogenous RARα[J]. Blood,2001,97 (5) :1314-1316.
  • 4Gabert J, Beillard E, van der Velden VHJ, et al. Standard- ization and quality control studies of′real-timer′quantita- tive reverse transcriptase polymerase chain reaction of fu- sion gene transcripts for residual disease detection in leu- kemia - A Europe Against Cancer Program[J]. Leukemia, 2003,17(12) : 2318-2320.
  • 5Ribeiro RC, Eduardo Rego. Management of APL in Devel- opeing Countries: Epidemiology Challenge and Opportuni- ties for International Collaboration [J]. Hematology, 2006,16(2) : 237-239.
  • 6Ghaffari SH,Rostami S, Bashash D, et al. Real-time PCR analysis of PML-RAR alpha in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic tri- oxide as a front-line therapy [J]. Ann Oncol, 2006, 17 (10) : 1553-1554.
  • 7Santamaria C, Chillon MC, Fernandez C, et al. Using quantifi- cation of the PML-RARα transcript to stratify the risk of re- lapse in patient with acute promelocytic leukemia[J], Haema- tologica,2007,92(3) :315-317.
  • 8Creutzig U, Ritter J, Zimmermann M, et al. Improved treat- ment results in high-risk pediatric acute myeloid leukemia pa- tients after intensification with high-dose cytarabine and mi- toxantrone~ results of Study Acute MyeIoid Leukemia-Berlin- Frankfurt-Manster 93[J]. J Clin Oncol,2001,19 (10) :2705- 2707.
  • 9de Botton S, Coiteux V, Chevret S, et al. Outcome of childhood acute promyelocytic leukemia with all-trans- retinoic acid and chemotherapy[J].J Clin Oneol, 2004,22 (8) : 1404-1406.
  • 10主鸿鹄,刘艳荣,秦亚溱,李金兰,常艳,王亚哲,单福香,江滨,陆道培.实时定量PCR检测46例初诊急性早幼粒细胞白血病患者PML/RARα mRNA的分子表达[J].中国实验血液学杂志,2007,15(1):1-5. 被引量:10

二级参考文献39

共引文献42

同被引文献40

  • 1刘朝阳.急性粒细胞缺乏症合并败血症误诊为早幼粒细胞白血病1例分析[J].中国误诊学杂志,2007,7(9):2053-2053. 被引量:1
  • 2GB/T28039--2011中国人名汉语拼音字母拼写规则[S].北京:中国标准出版社,2012.
  • 3GB/T16159--2012汉语拼音正词法基本规则[S].北京:中国标准出版社,2012.
  • 4陶伏平,丁加勇.GB/T16159--2012(汉语拼音正词法基本规则》解读[M].北京:中国标准出版社,2013.
  • 5中国学术期刊(光盘版)编辑委员会.CAJ-CDB/T1-2006中国学术期刊(光盘版)检索与评价数据规范:修订版[S].北京:中国学术期刊(光盘版)编辑委员会,2006.
  • 6Douer D. The epidemiology of acute promyelocytic leukae- mia[J]. Best Pract Res Clin Haematol, 2003,16 (3) : 357- 367.
  • 7Avvisati G,Lo-Coeo F,Paoloni FP,et al. AIDA 0493 pro- tocol for newly diagnosed acute promyeloeytie leukemia: very long-term results and role of maintenance[J]. Blood, 2011,117(18) :4716-4725.
  • 8Dai CW,Zhang GS,Shen JK,et al. Use of all-trans retino- ic acid in combination with Arsenic trioxide for remission induction in patients with newly diagnosed acute promye- locytic leukemia and for consolidation/maintenance in CR patients[J]. Acta Haematol, 2009,121 ( 1 ) : 1-8.
  • 9Creutzig U, Zimmermann M,Dworzak M, et al. Favoura- ble outcome of patients with childhood acute promyelo- cytic leukaemia after treatment with reduced cumulative anthracycline doses[J]. Br J Haematol, 2010,149 (3) : 399- 409.
  • 10Roxo-Junior P, Silva J, Andrea M, et al. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficien- cy[J]. Ital J Pediatr,2013,39(1) :54-58.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部